ΕΝ

Anti-bribery policy – Bioanalytica S.A.

The Management of BIOANALYTICA S.A. (hereinafter BIOANALYTICA) recognizes the risks of bribery and allocates all the required resources for the development and implementation of a comprehensive Anti-Bribery Management System, in accordance with the requirements of the international standard ISO 37001:2025.

As part of this system, documented procedures have been established and implemented to meet the requirements of the standard, ensuring effective Bribery prevention across all areas and activities of the company.

The Management of BIOANALYTICA throughout the company's operations:

þ  Prohibits all forms of Bribery, whether offering or accepting bribes.

þ  Implements strict anti-Bribery measures to uphold high ethical standards and protect the company’s reputation from any Bribery-related allegations.

þ  Requires full compliance from all employees with both anti-Bribery laws and the ISO 37001:2025 standard as applicable to the company.

þ  Encourages all personnel to raise concerns in good faith and report any case of suspected, attempted, or actual bribery, or non-compliance, without fear of retaliation, to the Company through the communication channels specified below. Requires all personnel to report any actual or potential conflict of interest related to Bribery.

þ  Enforces a zero-tolerance policy towards Bribery and is committed to conducting all business transactions with professionalism, legality, and integrity.

þ  Raises awareness and provides continuous training for employees on Bribery prevention through ongoing education programs.

þ  Has established an independent Compliance Committee (C.C.) separate from company management, which reports directly to the CEO and has the authority to investigate any suspected cases of Bribery.

þ  In the event of Bribery or non-compliance with the requirements of the anti-bribery management system, it imposes sanctions and, in case of violation of relevant legal requirements, takes appropriate measures.

þ  Imposes penalties in cases of Bribery or non-compliance with the Anti-Bribery Management System and takes appropriate measures in the event of legal violations.

Through the documentation of the Anti-Bribery Management System, the relevant requirements of interested parties regarding their compliance obligations, both with the applicable anti-bribery legal framework and their participation in the Management System, have been integrated into the operations of BIOANALYTICA.

This Anti-Bribery Management System applies to stakeholders involved in the execution of company projects, including all types of business partners (external suppliers and their business partners).

In this context, the Management of BIOANALYTICA S.A. is committed to supporting the implementation, control, and maintenance of the Anti-Bribery Management System, which will be periodically reviewed, revised, and improved when necessary, in order to continuously ensure its regulatory compliance both with the applicable legal framework and the requirements of the ISO 37001:2025 international anti-bribery standard.

 

REPORTING BRIBERY INCIDENTS

For any suspicion of Bribery within the scope of this Anti-Bribery Policy, you may contact the Company, either anonymously or by name, to the attention of the Report Receiving and Investigation Officer (RRIO), through the communication channels specified below:

-    Email: [email protected]

-    Mailing Address: 32 Ikoniou St., Nea Smyrni, P.C. 17123, Greece

-    Confidential Complaints Box (located in a designated area within the company)

 

Last Updated: 02/10/2026

SUPPORT

Trust,
Professionalism,
Expertise

BioAnalytica is the leading supplier of Biotechnology products & services in Greece & Cyprus, boasting specialized experience and comprehensive knowledge of industry developments. The company is dedicated to continuously seeking innovation and upholding scientific excellence.

This approach ensures that BioAnalytica provides customized and cutting-edge solutions, fostering strong partnerships while advancing education and expertise in Life Sciences and Advanced Diagnostics.

  • We listen, discuss, and analyze.
  • We provide tailored solutions based on each partner's needs.
  • We educate, develop, and share expertise.
espa_logo